SAFETY OF IV IRON THERAPY IN CHRONIC KIDNEY DISEASE PATIENTS

被引:0
|
作者
Bhandari, Sunil [1 ]
Myer, Vikki [1 ]
机构
[1] Hull & East Yorkshire Hosp NHS Trust, Renal Med, Kingston Upon Hull, Yorks, England
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
SP321
引用
收藏
页码:197 / 197
页数:1
相关论文
共 50 条
  • [1] Safety concerns about intravenous iron therapy in patients with chronic kidney disease
    Del Vecchio, Lucia
    Longhi, Selena
    Locatelli, Francesco
    [J]. CLINICAL KIDNEY JOURNAL, 2016, 9 (02) : 260 - 267
  • [2] THE SAFETY OF IRON POLYMALTOSE IN CHRONIC KIDNEY DISEASE PATIENTS
    Saunders, J.
    Aravindan, A. N.
    Knagge, D.
    Wong, J.
    Howlin, K. J.
    Cleland, B. G.
    Jefferys, A.
    Makris, A.
    Spicer, S. T.
    Suranyi, M. G.
    [J]. NEPHROLOGY, 2007, 12 : A45 - A45
  • [3] Special issue: iron therapy in patients with chronic kidney disease
    Macdougall, Iain C.
    [J]. CLINICAL KIDNEY JOURNAL, 2017, 10 : 1 - 2
  • [4] Improving the safety of intravenous iron treatments for patients with chronic kidney disease
    Kassianides, Xenophon
    Hazara, Adil Mohammad
    Bhandari, Sunil
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (01) : 23 - 35
  • [5] Efficacy of IV Iron Compared to Oral Iron for Increment of Haemoglobin Level in Anemic Chronic Kidney Disease Patients on Erythropoietin Therapy
    Adhikary, L.
    Acharya, S.
    [J]. JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2011, 51 (03) : 133 - 136
  • [6] Safety of cerebral angiography and neuroendovascular therapy in patients with chronic kidney disease
    Kim, Jae
    Male, Shailesh
    Jagadeesan, Bharathi D.
    Streib, Christopher
    Tummala, Ramachandra P.
    [J]. NEURORADIOLOGY, 2018, 60 (05) : 529 - 533
  • [7] Safety of cerebral angiography and neuroendovascular therapy in patients with chronic kidney disease
    Jae Kim
    Shailesh Male
    Bharathi D. Jagadeesan
    Christopher Streib
    Ramachandra P. Tummala
    [J]. Neuroradiology, 2018, 60 : 529 - 533
  • [8] The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients
    Spinowitz, BS
    Schwenk, MH
    Jacobs, PM
    Bolton, WK
    Kaplan, MR
    Charytan, C
    Galler, M
    [J]. KIDNEY INTERNATIONAL, 2005, 68 (04) : 1801 - 1807
  • [9] The comparative safety of various intravenous iron preparations in chronic kidney disease patients
    Ganguli, Anirban
    Kohli, H. S.
    Jha, Vivekanand
    Gupta, K. L.
    Sakhuja, Vinay
    [J]. RENAL FAILURE, 2008, 30 (06) : 629 - 638
  • [10] Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease
    Potthoff, S. A.
    Muench, H. G.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (24) : 1312 - 1317